HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) Removed old template contents |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis}} | {{DISPLAYTITLE:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 13: | Line 12: | ||
Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||